Timothy M. Mason

Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats.

Timothy M. Mason, Tracy Goh, Vaja Tchipashvili et al. · Diabetes · 1999 · 180 citations

Insulin Signaling, Insulin Secretory Response, Obesity +16

Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years

E. Jolly, Nina H. Bjarnason, Patrick Neven et al. · Menopause The Journal of The North American Menopause Society · 2003 · 107 citations

Raloxifene Does Not Affect Insulin Sensitivity or Glycemic Control in Postmenopausal Women with Type 2 Diabetes Mellitus: A Randomized Clinical Trial

Björn Andersson, Gudmundur Johannsson, Göran Holm et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 54 citations · Full text

Post hoc analysis of data from the Multiple Outcomes of Raloxifene Evaluation (MORE) trial on the effects of three years of raloxifene treatment on glycemic control and cardiovascular disease risk factors in women with and without type 2 diabetes

Elizabeth Barrett‐Connor, Kristine E. Ensrud, Kristine D. Harper et al. · Clinical Therapeutics · 2003 · 52 citations

Diabetes Management, Cardiovascular Disease, Diabetes +11

Lipid-induced β-cell dysfunction in vivo in models of progressive β-cell failure

Tracy Goh, Timothy M. Mason, Neehar Gupta et al. · American Journal of Physiology-Endocrinology and Metabolism · 2006 · 48 citations